Skip to main content

Annals of Surgical Oncology

Ausgabe 9/2013

Inhalt (51 Artikel)

Hepatobiliary Tumors

Hepatic Artery Infusion: Still an Option?

Lawrence D. Wagman

Healthcare Policy and Outcomes

The Financial Burden of Reexcising Incompletely Excised Soft Tissue Sarcomas: A Cost Analysis

Vignesh K. Alamanda, Gadini O. Delisca, Shannon L. Mathis, Kristin R. Archer, Jesse M. Ehrenfeld, Mark W. Miller, Kelly C. Homlar, Jennifer L. Halpern, Herbert S. Schwartz, Ginger E. Holt

Healthcare Policy and Outcomes

Population-Level Analysis of Pancreatic Neuroendocrine Tumors 2 cm or Less in Size

Eric J. Kuo, Ronald R. Salem

Open Access Healthcare Policy and Outcomes

Prognosis in Women with Breast Cancer and Private Extra Insurance Coverage

Juan J. Grau, Gabriel Zanon, Carlos Caso, Xavier Gonzalez, Araceli Rodriguez, Miguel Caballero, Albert Biete

Breast Oncology

Residual Lymph Node Disease After Neoadjuvant Chemotherapy Predicts an Increased Risk of Lymphedema in Node-Positive Breast Cancer Patients

Michelle C. Specht, Cynthia L. Miller, Melissa N. Skolny, Lauren S. Jammallo, Jean O’Toole, Nora Horick, Steven J. Isakoff, Barbara L. Smith, Alphonse G. Taghian

Breast Oncology

Fibrotic Focus in Breast Carcinomas: Relationship with Prognostic Parameters and Biomarkers

S. Shafaq Mujtaba, Yun-Bi Ni, Julia Y. S. Tsang, Siu-Ki Chan, Rin Yamaguchi, Maki Tanaka, Puay-Hoon Tan, Gary M. Tse

Breast Oncology

A Model to Predict the Risk of Upgrade to Malignancy at Surgery in Atypical Breast Lesions Discovered on Percutaneous Biopsy Specimens

Catherine Uzan, Chafika Mazouni, Malek Ferchiou, Laura Ciolovan, Corinne Balleyguier, Marie-Christine Mathieu, Philippe Vielh, Suzette Delaloge

Breast Oncology

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients with Cytologically Proven Node-positive Breast Cancer at Diagnosis

Seho Park, Ji Min Park, Jung Hoon Cho, Hyung Seok Park, Seung Il Kim, Byeong-Woo Park

Breast Oncology

Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer?

Tiffanie Jones, Hanmanth Neboori, H. Wu, Qifeng Yang, Bruce G. Haffty, Susan Evans, Susan Higgins, Meena S. Moran

Breast Oncology

Cost-Effectiveness Analysis of Intraoperative Radiation Therapy for Early-Stage Breast Cancer

Michael D. Alvarado, Aron J. Mohan, Laura J. Esserman, Catherine C. Park, Brittany L. Harrison, Rebecca J. Howe, Cristina Thorsen, Elissa M. Ozanne

Hepatobiliary Tumors

Long-Term Outcomes Comparing Surgery to Embolization-Ablation for Treatment of Solitary HCC <7 cm

Eldad Elnekave, Joseph P. Erinjeri, Karen T. Brown, Raymond H. Thornton, Elena N. Petre, Majid Maybody, Mary A. Maluccio, Meier Hsu, Constantinos T. Sofocleous, George I. Getrajdman, Lynn A. Brody, Stephen B. Solomon, William Alago, Yuman Fong, William R. Jarnagin, Anne M. Covey

Hepatobiliary Tumors

Financial Comparison of Laparoscopic Versus Open Hepatic Resection Using Deviation-Based Cost Modeling

Robert M. Cannon, Charles R. Scoggins, Glenda G. Callender, Amy Quillo, Kelly M. McMasters, Robert C. G. Martin II

Hepatobiliary Tumors

Gd-EOB-DTPA-Enhanced MRI is Better than MDCT in Decision Making of Curative Treatment for Hepatocellular Carcinoma

Sun Hong Yoo, Jong Young Choi, Jeong Won Jang, Si Hyun Bae, Seung Kew Yoon, Dong Goo Kim, Young Kyoung Yoo, Sung Eun Rha, Young Joon Lee, Eun Sun Jung

Hepatobiliary Tumors

Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution

John B. Ammori, Nancy E. Kemeny, Yuman Fong, Andrea Cercek, Ronald P. Dematteo, Peter J. Allen, T. Peter Kingham, Mithat Gonen, Philip B. Paty, William R. Jarnagin, Michael I. D’Angelica

Colorectal Cancer

Preoperative Plasma Hyperfibrinogenemia is Predictive of Poor Prognosis in Patients with Nonmetastatic Colon Cancer

Hae-Jung Son, Ji Won Park, Hee Jin Chang, Dae Yong Kim, Byung Chang Kim, Sun Young Kim, Sung Chan Park, Hyo Seong Choi, Jae Hwan Oh

Colorectal Cancer

Elevation of Preoperative s-CEA Concentration in Stage IIA Colorectal Cancer Can Also Be a High Risk Factor for Stage II Patients

Chan Wook Kim, Yong Sik Yoon, In Ja Park, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim

Colorectal Cancer

Modern Rectal Cancer Multidisciplinary Treatment: The Role of Radiation and Surgery

Marco E. Allaix, Alessandro Fichera

Colorectal Cancer

Multivisceral Resection in Colorectal Cancer: A Systematic Review

H. M. Mohan, M. D. Evans, J. O. Larkin, J. Beynon, D. C. Winter

Bone and Soft Tissue Sarcomas

Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience

Piotr Rutkowski, Alessandro Gronchi, Peter Hohenberger, Sylvie Bonvalot, Patrick Schöffski, Sebastian Bauer, Elena Fumagalli, Pawel Nyckowski, Buu-Phuc Nguyen, Jan Martijn Kerst, Marco Fiore, Elzbieta Bylina, Mathias Hoiczyk, Annemieke Cats, Paolo G. Casali, Axel Le Cesne, Jürgen Treckmann, Eberhard Stoeckle, Johannes. H. W. de Wilt, Stefan Sleijfer, Ronald Tielen, Winette van der Graaf, Cornelis Verhoef, Frits van Coevorden

Endocrine Tumors

Does Hürthle Cell Carcinoma of the Thyroid Have a Poorer Prognosis than Ordinary Follicular Thyroid Carcinoma?

Kiminori Sugino, Kaori Kameyama, Koichi Ito, Mitsuji Nagahama, Wataru Kitagawa, Hiroshi Shibuya, Keiko Ohkuwa, Takashi Uruno, Junko Akaishi, Akifumi Suzuki, Chie Masaki, Kunihiko Ito

Endocrine Tumors

Multicenter Institutional Experience of Surgically Resected Thymic Epithelial Tumors (TETs): An Observational Report on Behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone)

Giovenzio Genestreti, Luca Ampollini, Marco Angelo Burgio, Luigi Rolli, Stefano Sanna, Emanuela Scarpi, Manuela Monti, Luca Burgio Salvatore, Luciana Giannone, Antonio Santo, Maurizio Mezzetti, Claudia Casanova, Roberta Buosi, Michele Rusca, Dino Amadori, Giampaolo Gavelli

Endocrine Tumors

Is Potassium Iodide Solution Necessary Before Total Thyroidectomy for Graves Disease?

Myrick C. Shinall Jr., James T. Broome, Arielle Baker, Carmen C. Solorzano

Gastrointestinal Oncology

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Asian Patients: 100 Consecutive Patients in a Single Institution

Melissa Ching Ching Teo, Grace Hwei Ching Tan, Chee Kian Tham, Cindy Lim, Khee Chee Soo

Gastrointestinal Oncology

Esophagojejunal Reconstruction After Total Gastrectomy for Gastric Cancer Using a Transorally Inserted Anvil Delivery System

J. LaFemina, E. F. Viñuela, M. A. Schattner, H. Gerdes, V. E. Strong

Gastrointestinal Oncology

D2 Lymphadenectomy with Surgical Ex Vivo Dissection into Node Stations for Gastric Adenocarcinoma Can Be Performed Safely in Western Patients and Ensures Optimal Staging

Benjamin Schmidt, Kevin K. Chang, Ugwuji N. Maduekwe, Nicole Look-Hong, David W. Rattner, Gregory Y. Lauwers, John T. Mullen, Han-Kwang Yang, Sam S. Yoon

Gastrointestinal Oncology

Using Pretreatment Tumor Depth and Length to Select Esophageal Squamous Cell Carcinoma Patients for Nonoperative Treatment After Neoadjuvant Chemoradiotherapy

Yin-Kai Chao, Chen-Kan Tseng, Yu-Wen Wen, Yun-Hen Liu, Yung-Liang Wan, Cheng-Tung Chiu, Wen-Cheng Chang, Hsien-Kun Chang

Thoracic Oncology

Which is the Optimal Response Criteria for Evaluating Preoperative Treatment in Esophageal Cancer: RECIST or Histology?

Yukinori Kurokawa, Taro Shibata, Nobutoshi Ando, Shiko Seki, Hidenori Mukaida, Haruhiko Fukuda

Thoracic Oncology

Outcome of Patients with Esophageal Cancer: A Nationwide Analysis

Miao-Fen Chen, Yao-Hsu Yang, Chia-Hsuan Lai, Pau-Chung Chen, Wen-Cheng Chen

Thoracic Oncology

Assessment of Sentinel Node Concept in Esophageal Cancer Based on Lymph Node Micrometastasis

Takahiko Hagihara, Yoshikazu Uenosono, Takaaki Arigami, Tsutomu Kozono, Hideo Arima, Shigehiro Yanagita, Munetsugu Hirata, Katsuhiko Ehi, Hiroshi Okumura, Masataka Matsumoto, Yasuto Uchikado, Sumiya Ishigami, Shoji Natsugoe

Thoracic Oncology

Lymph Node Harvest in Esophageal Cancer After Neoadjuvant Chemoradiotherapy

Ravi Shridhar, Sarah E. Hoffe, Khaldoun Almhanna, Jill M. Weber, Michael D. Chuong, Richard C. Karl, Kenneth Meredith

Thoracic Oncology

REG1A Expression Status Suggests Chemosensitivity Among Advanced Thoracic Esophageal Squamous Cell Carcinoma Patients Treated with Esophagectomy Followed by Adjuvant Chemotherapy

Yusuke Sato, Satoru Motoyama, Hiroshi Nanjo, Satoru Ito, Kei Yoshino, Tomohiko Sasaki, Kuniaki Kuribayashi, Yushi Nagaki, Kazuhiro Imai, Hajime Saito, Yoshihiro Minamiya, Jun-ichi Ogawa

Thoracic Oncology

Nodal Skip Metastasis is not a Predictor of Survival in Thoracic Esophageal Squamous Cell Carcinoma

Zhengfei Zhu, Weiwei Yu, Hecheng Li, Kuaile Zhao, Weixin Zhao, Yawei Zhang, Menghong Sun, Qiao Wei, Haiquan Chen, Jiaqing Xiang, Xiaolong Fu

Gynecologic Oncology

Lung Resistance-Related Protein (LRP) Expression in Malignant Ascitic Cells as a Prognostic Marker for Advanced Ovarian Serous Carcinoma

Elizabeth H. Kerr, Peter J. Frederick, Michael E. Egger, Cecil R. Stockard, Jeffery Sellers, Debbie DellaManna, Denise K. Oelschlager, Hope M. Amm, Isam-Eldin Eltoum, J. Michael Straughn, Donald J. Buchsbaum, William E. Grizzle, Lacey R. McNally

Head and Neck Oncology

Outcomes and Prognostic Factors of Post-irradiation and de novo Sarcomas of the Head and Neck: A Histologically Matched Case-Control Study

Ming Sheng Yeang, Kaijun Tay, Whee Sze Ong, Anuradha Thiagarajan, Daniel Shao-Weng Tan, Tam Cam Ha, Patrick Tze-Hern Teo, Khee-Chee Soo, Hiang Khoon Tan, N. Gopalakrishna Iyer

Head and Neck Oncology

mTHPC-mediated Photodynamic Therapy of Early Stage Oral Squamous Cell Carcinoma: A Comparison to Surgical Treatment

Sebastiaan A. H. J. de Visscher, Lieuwe J. Melchers, Pieter U. Dijkstra, Baris Karakullukcu, I. Bing Tan, Colin Hopper, Jan L. N. Roodenburg, Max J. H. Witjes

Head and Neck Oncology

Thyroid Nodules with Bethesda System III Cytology: Can Ultrasonography Guide the Next Step?

Hye Mi Gweon, Eun Ju Son, Ji Hyun Youk, Jeong-Ah Kim

Melanomas

Is Head and Neck Melanoma Different from Trunk and Extremity Melanomas with Respect to Sentinel Lymph Node Status and Clinical Outcome?

Niloofar Fadaki, Rui Li, Brian Parrett, Grant Sanders, Suresh Thummala, Lea Martineau, Servando Cardona-Huerta, Suzette Miranda, Shih-Tsung Cheng, James R. Miller III, Mark Singer, James E. Cleaver, Mohammed Kashani-Sabet, Stanley P. L. Leong

Melanomas

Outcome of Clinical Stage III Melanoma Patients with FDG-PET and Whole-Body CT Added to the Diagnostic Workup

M. G. Niebling, E. Bastiaannet, O. S. Hoekstra, J. J. Bonenkamp, R. Koelemij, H. J. Hoekstra

Melanomas

Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma

David E. Gyorki, Jianda Yuan, Zhenyu Mu, Bushra Zaidi, Melissa Pulitzer, Klaus Busam, Mary S. Brady, Daniel G. Coit, James P. Allison, Jedd D. Wolchok, Charlotte E. Ariyan

Pancreatic Tumors

Preoperative Classification of Pancreatic Cystic Neoplasms: The Clinical Significance of Diagnostic Inaccuracy

Clifford S. Cho, Andrew J. Russ, Agnes G. Loeffler, Robert J. Rettammel, Gregory Oudheusden, Emily R. Winslow, Sharon M. Weber

Pancreatic Tumors

Posterior Approach for Laparoscopic Pancreaticoduodenectomy to Prevent Replaced Hepatic Artery Injury

Satoshi Ogiso, Claudius Conrad, Kenichiro Araki, Valeria Basso, Brice Gayet

Urologic Oncology

Diagnostic Ureteroscopy Independently Correlates with Intravesical Recurrence after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Hao Lun Luo, Chih Hsiung Kang, Yen Ta Chen, Yao Chi Chuang, Wei Ching Lee, Yuan Tso Cheng, Po Hui Chiang

Urologic Oncology

Gleason 5+4 Has Worse Oncological and Pathological Outcomes Compared with Gleason 4+5: Significance of Gleason 5 Pattern

Sey Kiat Lim, Kwang Hyun Kim, Tae-Young Shin, Byung Ha Chung, Sung Joon Hong, Young Deuk Choi, Koon Ho Rha

Urologic Oncology

Tumor Volume Adds Prognostic Value in Patients with Organ-Confined Prostate Cancer

Kwang Hyun Kim, Sey Kiat Lim, Tae-Young Shin, Dae Ryong Kang, Woong Kyu Han, Byung Ha Chung, Koon Ho Rha, Sung Joon Hong

Translational Research and Biomarkers

XB130 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma

Atsushi Shiozaki, Toshiyuki Kosuga, Daisuke Ichikawa, Shuhei Komatsu, Hitoshi Fujiwara, Kazuma Okamoto, Daisuke Iitaka, Shingo Nakashima, Hiroki Shimizu, Takeshi Ishimoto, Maki Kitagawa, Yoshito Nakou, Mitsuo Kishimoto, Mingyao Liu, Eigo Otsuji

Breast Oncology

Supporting Trials for Primary Tumor Resection in Stage IV Breast Cancer is Paramount

Elly Harris, Mitchel Barry, Malcolm R. Kell

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.